The ACCESS program integrates device-generated data, AI-driven insights, and a dedicated virtual care team to manage cardiometabolic conditions — hypertension, dyslipidemia, CKD, obesity, and diabetes — meeting patients where they are, in their homes, across up to 50 states. Create and manage holistic, evidence-based care plans for patients with ACCESS-defined conditions: obesity, dyslipidemia, hypertension, ASCVD, mild-to-moderate CKD, and pre/diabetes.